Current data suggest that patients with IBD who carry specific gene alleles are at high risk of low anti-TNF blood concentrations and can develop immunogenicity to these drugs, as observed in the prospective study Personalized Anti-TNF Therapy in Crohn’s Disease (PANTS) [31]. The gene discussed is TNF; the disease is Crohn disease.